GSK PLC (GSK)
40.91
+0.05
(+0.12%)
USD |
NYSE |
Apr 25, 16:00
41.00
+0.09
(+0.22%)
Pre-Market: 08:47
GSK Change in Payables and Accrued Expense (Quarterly)
Change in Payables and Accrued Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Change in Payables and Accrued Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2007 | -- |
September 30, 2007 | -- |
June 30, 2007 | -- |
March 31, 2007 | -- |
December 31, 2006 | -- |
September 30, 2006 | -- |
June 30, 2006 | -- |
March 31, 2006 | -- |
December 31, 2005 | -- |
September 30, 2005 | -- |
June 30, 2005 | -- |
March 31, 2005 | -- |
December 31, 2004 | -- |
September 30, 2004 | -- |
June 30, 2004 | -- |
March 31, 2004 | -- |
Date | Value |
---|---|
December 31, 2003 | -- |
September 30, 2003 | -- |
June 30, 2003 | -- |
March 31, 2003 | -- |
December 31, 2002 | -- |
September 30, 2002 | -- |
June 30, 2002 | -- |
March 31, 2002 | -- |
December 31, 2001 | -- |
September 30, 2001 | -- |
June 30, 2001 | -- |
March 31, 2001 | -- |
December 31, 2000 | -- |
September 30, 2000 | -- |
June 30, 2000 | -- |
March 31, 2000 | -- |
Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Change in Payables and Accrued Expense (Quarterly) Benchmarks
AstraZeneca PLC | -- |
Haleon PLC | -- |
Novo Nordisk A/S | -- |
Pfizer Inc | -- |
Sanofi SA | -- |